Skip to content

BePharBel Manufacturing

Active
Public limited companyfounded 201214 yrs activeRue du Luxembourg(CO) 13, 6180 Courcelles, BelgiumKBO/BCE: BE 0844.689.955
Summary

BePharBel Manufacturing has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €4.36M and a net result of €-2.98M. Equity remains stable across the filed fiscal years (±0.6% per year). Its solvency ranks better than 16% of 85 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2024
Axes · tick = 2023
Profitability43▼-8
Solvency41▼-13
Growth40▼-30
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €220k at 30 days acceptable
Liquidity tight (current ratio 1.05 against 0.97 in 2023; short-term debt: 35.4% and cash: 5% of total assets), and 83.8% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 14 years 0 20 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
16.2%
Return on assets
-11.1%
Age of the figures
21 mo
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024
Net result per financial year
18192021222324
2018 to 2024 · latest year €-2.98M
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 85 sector peers (2024).
NBB · sector comparison
Position among 85 sector peers
Solvency
better than 16%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
34 d early
2023
36 d early
2022
62 d early
2021
59 d early
2020
46 d early
2019
69 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover
€17.13M▲ 9.3%
2023 · €15.67M
2018: €11.47Mlowest in 7 years 2019: €11.97M▲ +4.4% vs 2018 2020: €12.05M▲ +0.7% vs 2019 2021: €14.26M▲ +18.3% vs 2020 2022: €12.75M▼ -10.5% vs 2021 2023: €15.67M▲ +22.9% vs 2022 2024: €17.13M▲ +9.3% vs 2023highest in 7 years
2018 → 2024
EBIT margin
-11.4%▼ 3.8pp
2023 · -7.6%
2018: -14.9% 2019: -13.7%▲ +8.3% vs 2018 2020: -16.0%▼ -16.6% vs 2019lowest in 7 years 2021: -3.7%▲ +76.7% vs 2020 2022: 11.6%▲ +411% vs 2021highest in 7 years 2023: -7.6%▼ -166% vs 2022 2024: -11.4%▼ -50.5% vs 2023
2018 → 2024
Net result
€-2.98M▼ 70.2%
2023 · €-1.75M
2018: €-2.18M 2019: €-2.18M▼ -0.1% vs 2018 2020: €-2.38M▼ -9.1% vs 2019 2021: €-1.03M▲ +56.8% vs 2020 2022: €933k▲ +191% vs 2021highest in 7 years 2023: €-1.75M▼ -287% vs 2022 2024: €-2.98M▼ -70.2% vs 2023lowest in 7 years
2018 → 2024
Working capital
€447k
2023 · €-299k
2018: €-806k 2019: €-1.98M▼ -146% vs 2018 2020: €-2.57M▼ -29.3% vs 2019 2021: €-2.66M▼ -3.5% vs 2020lowest in 7 years 2022: €-624k▲ +76.5% vs 2021 2023: €-299k▲ +52.0% vs 2022 2024: €447k▲ +249% vs 2023highest in 7 years
2018 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Turnover€12.05M-€14.26M▲ 18.3%€12.75M▼ 10.5%€15.67M▲ 22.9%€17.13M▲ 9.3% 2020: €12.05Mlowest in 5 years 2021: €14.26M▲ +18.3% vs 2020 2022: €12.75M▼ -10.5% vs 2021 2023: €15.67M▲ +22.9% vs 2022 2024: €17.13M▲ +9.3% vs 2023highest in 5 years
Equity€5.00M-€6.19M▲ 23.9%€7.86M▲ 27.0%€7.55M▼ 4.0%€4.36M▼ 42.3% 2020: €5.00M 2021: €6.19M▲ +23.9% vs 2020 2022: €7.86M▲ +27.0% vs 2021highest in 5 years 2023: €7.55M▼ -4.0% vs 2022 2024: €4.36M▼ -42.3% vs 2023lowest in 5 years
Operating result€-1.92M-€-530k▲ 72.4%€1.47M€-1.19M€-1.96M▼ 64.5% 2020: €-1.92M 2021: €-530k▲ +72.4% vs 2020 2022: €1.47M▲ +378% vs 2021highest in 5 years 2023: €-1.19M▼ -181% vs 2022 2024: €-1.96M▼ -64.5% vs 2023lowest in 5 years
Net result€-2.38M-€-1.03M▲ 56.8%€933k€-1.75M€-2.98M▼ 70.2% 2020: €-2.38M 2021: €-1.03M▲ +56.8% vs 2020 2022: €933k▲ +191% vs 2021highest in 5 years 2023: €-1.75M▼ -287% vs 2022 2024: €-2.98M▼ -70.2% vs 2023lowest in 5 years
Result per fiscal year
Operating resultNet result
€-4.00M€-2.00M€0€2.00MOperating result 2020: €-1.92M€-1.92MNet result 2020: €-2.38M€-2.38MOperating result 2021: €-530k€-530kNet result 2021: €-1.03M€-1.03MOperating result 2022: €1.47M€1.47MNet result 2022: €933k€933kOperating result 2023: €-1.19M€-1.19MNet result 2023: €-1.75M€-1.75MOperating result 2024: €-1.96M€-1.96MNet result 2024: €-2.98M€-2.98M20202021202220232024€-4M€-2M€0€2MOperating result 2022: €1.47M€1.5MNet result 2022: €933k€933kOperating result 2023: €-1.19M€-1.2MNet result 2023: €-1.75M€-1.7MOperating result 2024: €-1.96M€-2MNet result 2024: €-2.98M€-3M202220232024
The operating result stays negative: a loss of €1.96M in 2024 against €1.19M in 2023; the loss grows and 2024 has the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €26.93M
Fixed assets €16.95M ▼ 2.2%
Current assets €9.98M ▲ 9.9%
Equity and liabilities €26.93M
Equity €4.36M ▼ 42.3%
Debt €22.57M ▲ 19.7%
Debt's share of the balance-sheet total rises from 71.4% to 83.8%. Equity is lower and debt is higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€2.47M▲
2023 · €2.17M
Cash flow
€1.45M▼
2023 · €1.61M
Current ratio
1.05▲
2023 · 0.97
Quick ratio
0.67▲
2023 · 0.59
Debt to equity
5.18▲
2023 · 2.50
ROE
-68.3%▼
2023 · -23.2%
ROA
-11.1%▼
2023 · -6.6%
Interest coverage
2.49▼
2023 · 3.40
Debt ≤ 1 year
€9.53M▲
2023 · €9.37M
Debt > 1 year
€12.87M▲
2023 · €9.29M
Income taxes
€5k▲
2023 · €-117k
Staff costs
€7.14M▲
2023 · €6.02M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 90 lines
Balance sheet Code20232024
Assets
Total assets20/58€26.40M€26.93M▲
Fixed assets21/28€17.33M€16.95M▼
Intangible fixed assets21€3.60M€4.14M▲
Tangible fixed assets22/27€13.73M€12.80M▼
Land and buildings22€1.43M€1.49M▲
Plant, machinery and equipment23€9.78M€9.31M▼
Furniture and vehicles24€522k€465k▼
Leasing and similar rights25€1.14M€1,000k▼
Other tangible fixed assets26€0€0=
Assets under construction and advance payments27€857k€538k▼
Financial fixed assets28€5k€5k=
Other financial fixed assets284/8€5k€5k=
Amounts receivable and cash guarantees285/8€5k€5k=
Current assets29/58€9.07M€9.98M▲
Stocks and contracts in progress3€3.57M€3.57M▼
Stocks30/36€3.57M€3.57M▼
Raw materials and consumables30/31€2.28M€2.34M▲
Work in progress32€337k€300k▼
Finished goods33€800k€933k▲
Advance payments36€155k€0▼
Amounts receivable within one year40/41€4.48M€5.03M▲
Trade receivables40€3.05M€4.60M▲
Other amounts receivable41€1.43M€423k▼
Cash at bank and in hand54/58€882k€1.34M▲
Deferred charges and accrued income490/1€133k€41k▼
Equity and liabilities
Total equity and liabilities10/49€26.40M€26.93M▲
Equity10/15€7.55M€4.36M▼
Contributions10/11€9.30M€9.30M=
Capital10€6.76M€6.70M▼
Issued capital100€6.76M€6.70M▼
Outside capital11€2.54M€2.60M▲
Share premium1100/10€2.54M€2.60M▲
Reserves13€724k€724k=
Distributable reserves133€724k€724k=
Profit (loss) carried forward14€-5.84M€-8.82M▼
Investment grants15€3.37M€3.15M▼
Amounts payable17/49€18.85M€22.57M▲
Amounts payable after more than one year17€9.29M€12.87M▲
Financial debts170/4€8.54M€11.82M▲
Subordinated loans170€4.17M€8.41M▲
Leasing and similar obligations172€1.06M€883k▼
Credit institutions173€2.90M€2.24M▼
Other loans174€405k€287k▼
Other amounts payable178/9€754k€1.05M▲
Amounts payable within one year42/48€9.37M€9.53M▲
Current portion of amounts payable after more than one year42€1.31M€1.25M▼
Financial debts43€3.86M€2.73M▼
Credit institutions430/8€3.86M€2.73M▼
Trade debts44€2.05M€3.08M▲
Suppliers440/4€2.05M€3.08M▲
Advances received on contracts in progress46€755k€623k▼
Taxes, remuneration and social security45€1.05M€1.42M▲
Taxes450/3€243k€209k▼
Remuneration and social security454/9€807k€1.21M▲
Other amounts payable47/48€337k€424k▲
Accrued charges and deferred income492/3€187k€174k▼
Income statement Code20232024
Operating income70/76A€20.48M€22.27M▲
Turnover70€15.67M€17.13M▲
Change in stocks of work in progress, finished goods and contracts in progress71€246k€95k▼
Own construction capitalised72€3.00M€3.44M▲
Other operating income74€1.57M€1.60M▲
Operating charges60/66A€21.67M€24.23M▲
Goods for resale, raw materials and consumables60€5.43M€4.78M▼
Purchases600/8€5.36M€5.03M▼
Change in stocks: decrease (increase)609€70k€-243k▼
Services and other goods61€6.52M€7.22M▲
Remuneration, social security and pensions62€6.02M€7.14M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3.36M€4.42M▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€190k
Provisions for liabilities and charges: additions (uses and reversals)635/8€-40k€0▲
Other operating charges640/8€393k€477k▲
Operating profit (loss)9901€-1.19M€-1.96M▼
Financial income75/76B€21€7k▲
Recurring financial income75€21€2k▲
Other financial income752/9€21€2k▲
Non-recurring financial income76B-€5k
Financial charges65/66B€676k€1.02M▲
Recurring financial charges65€676k€1.02M▲
Debt charges650€638k€989k▲
Other financial charges652/9€38k€32k▼
Non-recurring financial charges66B-€410
Profit (loss) for the period before taxes9903€-1.87M€-2.97M▼
Income taxes67/77€-117k€5k▲
Taxes670/3€5k€5k▲
Tax adjustments and reversals of tax provisions77€122k-
Profit (loss) for the period9904€-1.75M€-2.98M▼
Profit (loss) for the period to be appropriated9905€-1.75M€-2.98M▼
Appropriation of the result
Profit (loss) to be appropriated9906€-5.84M€-8.82M▼
Profit (loss) brought forward from the previous period14P€-4.09M€-5.84M▼
Social balance
Average headcount (FTE)908783.392.5▲

The notes to these accounts (93 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20202021202220232024Change
Operating income70/76A-€16.06M€19.73M€20.48M€22.27M▲ 8.7%
Turnover70€12.05M€14.26M€12.75M€15.67M€17.13M▲ 9.3%
Change in stocks of work in progress, finished goods and contracts in progress71-€-441k€201k€246k€95k▼ 61.3%
Own construction capitalised72-€1.06M€1.26M€3.00M€3.44M▲ 14.9%
Other operating income74-€1.19M€1.31M€1.57M€1.60M▲ 2.3%
Non-recurring operating income76A--€4.20M---
Operating charges60/66A-€16.59M€18.26M€21.67M€24.23M▲ 11.8%
Goods for resale, raw materials and consumables60-€3.26M€4.39M€5.43M€4.78M▼ 11.8%
Purchases600/8-€3.42M€4.96M€5.36M€5.03M▼ 6.2%
Change in stocks: decrease (increase)609-€-163k€-568k€70k€-243k▼ 449%
Services and other goods61-€4.69M€4.89M€6.52M€7.22M▲ 10.7%
Remuneration, social security and pensions62-€5.44M€5.79M€6.02M€7.14M▲ 18.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2.71M€2.61M€2.78M€3.36M€4.42M▲ 31.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€94k€124k-€190k-
Provisions for liabilities and charges: additions (uses and reversals)635/8--€-36k€-40k€0▲ 100%
Other operating charges640/8-€463k€308k€393k€477k▲ 21.5%
Non-recurring operating charges66A-€40k----
Operating profit (loss)9901€-1.92M€-530k€1.47M€-1.19M€-1.96M▼ 64.5%
Financial income75/76B-€2k€6k€21€7k▲ 32,393%
Recurring financial income75€4k€2k€6k€21€2k▲ 10,400%
Other financial income752/9-€2k€6k€21€2k▲ 10,400%
Non-recurring financial income76B----€5k-
Financial charges65/66B-€551k€603k€676k€1.02M▲ 51.0%
Recurring financial charges65€496k€551k€603k€676k€1.02M▲ 51.0%
Debt charges650€472k€504k€542k€638k€989k▲ 55.0%
Other financial charges652/9-€47k€61k€38k€32k▼ 16.4%
Non-recurring financial charges66B----€410-
Profit (loss) for the period before taxes9903€-2.41M€-1.08M€877k€-1.87M€-2.97M▼ 59.3%
Income taxes67/77€-37k€-52k€-56k€-117k€5k▲ 105%
Taxes670/3--€4k€5k€5k▲ 4.0%
Tax adjustments and reversals of tax provisions77-€52k€60k€122k--
Profit (loss) for the period9904€-2.38M€-1.03M€933k€-1.75M€-2.98M▼ 70.2%
Profit (loss) for the period to be appropriated9905€-2.38M€-1.03M€933k€-1.75M€-2.98M▼ 70.2%
Line20202021202220232024Change
Assets
Total assets20/58€25.29M€26.69M€25.67M€26.40M€26.93M▲ 2.0%
Fixed assets21/28€16.70M€17.67M€16.84M€17.33M€16.95M▼ 2.2%
Intangible fixed assets21€2.52M€2.20M€2.30M€3.60M€4.14M▲ 15.2%
Tangible fixed assets22/27€14.06M€15.46M€14.54M€13.73M€12.80M▼ 6.7%
Land and buildings22-€1.58M€1.54M€1.43M€1.49M▲ 4.3%
Plant, machinery and equipment23-€11.48M€10.54M€9.78M€9.31M▼ 4.8%
Furniture and vehicles24-€805k€651k€522k€465k▼ 10.9%
Leasing and similar rights25-€1.41M€1.27M€1.14M€1,000k▼ 12.0%
Other tangible fixed assets26---€0€0-
Assets under construction and advance payments27-€185k€533k€857k€538k▼ 37.2%
Financial fixed assets28€126k€5k€5k€5k€5k=
Other financial fixed assets284/8-€5k€5k€5k€5k=
Amounts receivable and cash guarantees285/8-€5k€5k€5k€5k=
Current assets29/58€8.58M€9.03M€8.83M€9.07M€9.98M▲ 9.9%
Stocks and contracts in progress3€3.08M€2.74M€3.40M€3.57M€3.57M▼ 0.2%
Stocks30/36-€2.74M€3.40M€3.57M€3.57M▼ 0.2%
Raw materials and consumables30/31-€1.90M€2.35M€2.28M€2.34M▲ 2.3%
Work in progress32-€258k€292k€337k€300k▼ 11.1%
Finished goods33-€432k€599k€800k€933k▲ 16.6%
Advance payments36-€155k€155k€155k€0▼ 100%
Amounts receivable within one year40/41€4.37M€5.44M€4.46M€4.48M€5.03M▲ 12.1%
Trade receivables40-€3.21M€3.53M€3.05M€4.60M▲ 50.9%
Other amounts receivable41-€2.23M€930k€1.43M€423k▼ 70.5%
Cash at bank and in hand54/58€1.09M€643k€942k€882k€1.34M▲ 51.9%
Deferred charges and accrued income490/1-€200k€30k€133k€41k▼ 69.1%
Equity and liabilities
Total equity and liabilities10/49€25.29M€26.69M€25.67M€26.40M€26.93M▲ 2.0%
Equity10/15€5.00M€6.19M€7.86M€7.55M€4.36M▼ 42.3%
Contributions10/11€11.32M€6.90M€7.92M€9.30M€9.30M=
Capital10-€6.13M€6.37M€6.76M€6.70M▼ 1.0%
Issued capital100-€6.13M€6.37M€6.76M€6.70M▼ 1.0%
Outside capital11-€768k€1.55M€2.54M€2.60M▲ 2.6%
Share premium1100/10-€768k€1.55M€2.54M€2.60M▲ 2.6%
Reserves13€724k€724k€724k€724k€724k=
Distributable reserves133-€724k€724k€724k€724k=
Profit (loss) carried forward14€-13.00M€-5.02M€-4.09M€-5.84M€-8.82M▼ 51.0%
Investment grants15-€3.59M€3.32M€3.37M€3.15M▼ 6.5%
Provisions and deferred taxes16€300k€300k€264k---
Provisions for liabilities and charges160/5-€300k€264k---
Other liabilities and charges164/5-€300k€264k---
Amounts payable17/49€19.99M€20.20M€17.54M€18.85M€22.57M▲ 19.7%
Amounts payable after more than one year17€8.80M€8.41M€8.01M€9.29M€12.87M▲ 38.5%
Financial debts170/4-€7.95M€7.48M€8.54M€11.82M▲ 38.5%
Subordinated loans170-€2.00M€2.15M€4.17M€8.41M▲ 102%
Leasing and similar obligations172-€1.40M€1.23M€1.06M€883k▼ 16.9%
Credit institutions173-€3.89M€3.54M€2.90M€2.24M▼ 22.7%
Other loans174-€664k€556k€405k€287k▼ 29.1%
Other amounts payable178/9-€464k€533k€754k€1.05M▲ 39.1%
Amounts payable within one year42/48€11.15M€11.68M€9.45M€9.37M€9.53M▲ 1.7%
Current portion of amounts payable after more than one year42-€2.77M€1.55M€1.31M€1.25M▼ 5.1%
Financial debts43-€4.32M€2.89M€3.86M€2.73M▼ 29.4%
Credit institutions430/8-€4.32M€2.89M€3.86M€2.73M▼ 29.4%
Trade debts44€3.61M€2.14M€2.65M€2.05M€3.08M▲ 50.3%
Suppliers440/4-€2.14M€2.65M€2.05M€3.08M▲ 50.3%
Advances received on contracts in progress46-€853k€818k€755k€623k▼ 17.5%
Taxes, remuneration and social security45-€1.26M€1.20M€1.05M€1.42M▲ 35.2%
Taxes450/3-€251k€267k€243k€209k▼ 14.3%
Remuneration and social security454/9-€1.00M€933k€807k€1.21M▲ 50.2%
Other amounts payable47/48-€345k€345k€337k€424k▲ 25.9%
Accrued charges and deferred income492/3-€110k€76k€187k€174k▼ 7.1%
Line20202021202220232024Change
Profit (loss) for the period9904€-2.38M€-1.03M€933k€-1.75M€-2.98M▼ 70.2%
+ Depreciation and write-downs630€2.71M€2.61M€2.78M€3.36M€4.42M▲ 31.7%
Operating cash flow (approximation)€333k€1.58M€3.71M€1.61M€1.45M▼ 10.2%
Investment in fixed assets (approximation)-€-3.57M€-1.95M€-3.85M€-4.05M▼ 5.2%
Change in cash-€-444k€299k€-60k€458k▲ 868%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

2026
11-08
State Gazette act Capital & shares · Resignations & appointments · Restructuring
Permanent representative: Gery LEFEBVRE · Demerger · Net-asset statement20 facts ▸
  • General meeting, 10/07/2026
  • Demerger, Scission partielle par constitution d'une société anonyme Novaform Pharma. Transfert de la branche d'activités MMCR.
  • Net-asset statement, 31/12/2025
  • Capital decrease, €-4.238.390
  • Capital, €7.664.142,35
  • Share issue, Actions entièrement libérées attribuées aux actionnaires de la société scindée
  • Share transfer, BePharBel Manufacturing → Sambrinvest Spin-Off/Spin-Out SA
  • Share transfer, BePharBel Manufacturing → Iris Belgium SRL
  • Share transfer, BePharBel Manufacturing → Talence SA
  • Share transfer, BePharBel Manufacturing → Vinsovier Société simple
  • Share transfer, BePharBel Manufacturing → CANA Société simple
  • Share transfer, BePharBel Manufacturing → Georges Guillaume
  • +8 further facts in this act
07-01
State Gazette act Appointment: Deloitte Réviseurs d'entreprises SRL (commissaire aux comptes)
2 facts ▸
  • General meeting, 15/05/2025
  • Auditor appointment, Deloitte Réviseurs d'entreprises SRL (commissaire aux comptes)
2025
08-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney7 facts ▸
  • General meeting, 30/05/2025
  • Capital increase, €2.173.956,35
  • Capital increase, €2.160.256,61
  • Capital increase, €536.343,11
  • Capital, €13.109.287,35
  • Statutes amendment
  • Power of attorney, Vincent Stéphenne
27-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
04-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney7 facts ▸
  • Capital increase, €357.562,07
  • Capital increase, €2.195.605,31
  • Capital increase, €2.232.780,34
  • Capital increase, €536.343,11
  • Capital, €12.667.116,92
  • Statutes amendment, 12bis
  • Power of attorney, Vincent Stéphenne
21-05
State Gazette act Restructuring
Capital · Merger · Net-asset statement10 facts ▸
  • General meeting, 18/04/2025
  • Capital, €6.698.350,2
  • Merger, 18/04/2025
  • Net-asset statement, 31/12/2024
  • Share issue, actions nouvelles, 87928
  • Capital increase, €1.182.819
  • Share cancellation, 87928
  • Capital, €7.881.169,2
  • Power of attorney, BePharBel Manufacturing
  • Accounting effect, 01/01/2025
27-02
State Gazette act Capital & shares · Restructuring · Miscellaneous
Appointment: Deloitte Réviseurs d'Entreprises SRL (commissaire pour rapport augmentation capital par apport en nature) · Merger · Share issue6 facts ▸
  • Merger
  • Share issue, 87928, fusion
  • Share cancellation, 87928, actions propres acquises suite à la fusion
  • Capital decrease, €1.206.755
  • Accounting effect, 01/01/2025
  • Auditor appointment, Deloitte Réviseurs d'Entreprises SRL (commissaire pour rapport augmentation capital par apport en nature)
2024
31-12
Financial Weakest financial yearnet €-2.98M
Net result drops to €-2.98M, the lowest in the series.
11-10
State Gazette act Reappointments: de Rochechouart de Mortemart Antoine, Wolkonsky Cyril and 6 others
Permanent representatives: Bernard Jolly, Jean-Jacques Delens and Fabrice Carosella12 facts ▸
  • General meeting, 8 mai 2024
  • Director reappointment, de Rochechouart de Mortemart Antoine (director)
  • Director reappointment, Wolkonsky Cyril (director)
  • Director reappointment, Stephenne Jean (director)
  • Director reappointment, Stephenne Vincent (director)
  • Director reappointment, Noël Yves (director)
  • Director reappointment, Nomainvest SA (director)
  • Director reappointment, TALENCE SA (director)
  • Director reappointment, SAMBRINVEST SO/SO (director)
  • Permanent representative, Bernard Jolly
  • Permanent representative, Jean-Jacques Delens
  • Permanent representative, Fabrice Carosella
25-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
08-12
State Gazette act Resignations: Anne Prignon (director) and Jacques Reymann (director)
Appointments: Denis Bedoret (independent director) and Bernard Pluta (independent director) · Mandate compensation7 facts ▸
  • General meeting, 10/05/2023
  • Director resignation, Anne Prignon (director)
  • Director resignation, Jacques Reymann (director)
  • Director appointment, Denis Bedoret (independent director)
  • Director appointment, Bernard Pluta (independent director)
  • Mandate compensation, Denis Bedoret
  • Mandate compensation, Bernard Pluta
24-11
State Gazette act Appointment: Deloitte Reviseur d'Entreprises (commissaire aux comptes)
2 facts ▸
  • General meeting, 11/05/2022
  • Auditor appointment, Deloitte Reviseur d'Entreprises (commissaire aux comptes)
Show earlier events
06-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bank account8 facts ▸
  • Capital increase, €21.470,52
  • Share issue, 1.920, 45,00 €
  • Capital increase, €306.010,83
  • Share issue, 27.365, 47,50 €
  • Bank account, ING
  • Capital, €6.698.355,13
  • Statutes amendment
  • Power of attorney, directors
30-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Back to profitnet €933k
Net result €933k after 4 loss-making years.
02-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
04-05
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital4 facts ▸
  • Capital increase, €239.184,92
  • Bank account, ING Belgique
  • Capital, €6.370.873,78
  • Statutes amendment
2021
31-12
Financial Equity above €5MEq €6.19M ▲23.9%
Equity rises from €5.00M to €6.19M.
17-11
State Gazette act Reappointments: Anne Prignon, Jean Stéphenne and 7 others
Permanent representatives: Jean-Jacques Delens and Bernard Jolly12 facts ▸
  • Director reappointment, Anne Prignon (director)
  • Director reappointment, Jean Stéphenne (director)
  • Director reappointment, Vincent Stéphenne (director)
  • Director reappointment, Vincent Stéphenne (managing director)
  • Director reappointment, Cyril Wolkonsky (director)
  • Director reappointment, Antoine de Rochechouart de Mortemart (director)
  • Director reappointment, Talence (director)
  • Permanent representative, Jean-Jacques Delens
  • Director reappointment, Jacques Reymarın (director)
  • Director reappointment, Cheniclem Private Equity (director)
  • Permanent representative, Bernard Jolly
  • Director reappointment, Yves Noël (director)
26-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital3 facts ▸
  • Capital increase, €236.479,36
  • Bank account, ING Belgique
  • Capital, €6.131.688,86
07-07
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital3 facts ▸
  • Capital decrease
  • Capital, €5.895.209,5
  • Statutes amendment
15-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
27-04
State Gazette act Appointment: Vincent Stéphenne (managing director)
Mandate compensation3 facts ▸
  • Board meeting, 25/01/2021
  • Director appointment, Vincent Stéphenne (managing director)
  • Mandate compensation, Vincent Stéphenne
2020
23-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital5 facts ▸
  • Capital increase, €6.979.040,06
  • Capital increase, €1.079.114
  • Bank account, ING, 1.422.622,00 €
  • Capital, €12.129.114
  • Statutes amendment
08-10
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 69 days late
15-05
State Gazette act Appointment: Deloite Reviseur d'Entreprises (commissaire aux comptes)
2 facts ▸
  • General meeting, 08/05/2019
  • Auditor appointment, Deloite Reviseur d'Entreprises (commissaire aux comptes)
2019
12-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital3 facts ▸
  • Capital increase, €178.554,88
  • Bank account, ING
  • Capital, €4.070.959,94
24-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
10-04
State Gazette act Capital & shares
Capital increase · Bank account · Capital3 facts ▸
  • Capital increase, €178.554,88
  • Bank account, ING
  • Capital, €3.892.405,06
2018
12-10
State Gazette act Capital & shares
Capital increase · Bank account · Capital4 facts ▸
  • Capital increase, €356.925,09
  • Bank account, ING
  • Capital, €3.713.850,18
  • Statutes amendment
28-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
19-03
State Gazette act Capital & shares
Capital increase · Bank account · Capital3 facts ▸
  • Capital increase, €356.925,09
  • Bank account, BE67 3631 7160 7487
  • Capital, €3.356.925,09
11-01
State Gazette act Capital & shares
Reserve release · Capital decrease · Capital4 facts ▸
  • Reserve release, Réduction des primes d'émission par apurement des pertes
  • Capital decrease, €539.230
  • Capital, €3.000.000
  • Statutes amendment
2017
28-11
State Gazette act Resignations: Anne PRIGNON, Jean STÉPHENNE and 7 others
Appointments: Anne PRIGNON, Jean STÉPHENNE and 7 others · Permanent representatives: Jean-Jacques DELENS and Bernard JOLLY · Capital increase27 facts ▸
  • General meeting, 08/11/2017
  • Capital increase, €421.060
  • Bank account, ING
  • Capital, €3.539.230
  • Director resignation, Anne PRIGNON (director)
  • Director resignation, Jean STÉPHENNE (director)
  • Director resignation, Christian VANDECASSERIE (director)
  • Director resignation, Wolf Sylvain LANDAU (director)
  • Director resignation, Jacques REYMANN (director)
  • Director resignation, Cyril WOLKONSKY (director)
  • Director resignation, Antoine de ROCHECHOUART de MORTEMART (director)
  • Director resignation, TALENCE (director)
  • +15 further facts in this act
31-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 31 days late
12-04
State Gazette act Capital & shares
Capital increase · Premium account · Bank account4 facts ▸
  • Capital increase, €289.670
  • Premium account, compte de prime d'émission, compte indisponible
  • Bank account, ING, 1.375.932,50 €
  • Capital, €3.118.170
2016
29-07
State Gazette act Appointment: Deloitte Réviseur d'Entreprises (commissaire aux comptes)
2 facts ▸
  • General meeting, 11/05/2016
  • Auditor appointment, Deloitte Réviseur d'Entreprises (commissaire aux comptes)
11-07
State Gazette act Capital & shares · Resignations & appointments
Capital increase · Capital · Bank account4 facts ▸
  • Capital increase, €263.720
  • Capital, €2.828.500
  • Bank account, BNP PARIBAS FORTIS, 1.252.670,00 €
  • Statutes amendment
08-07
NBB filing Annual accounts filed
fiscal year 2015 · full schema
2015
16-07
State Gazette act Restructuring · Miscellaneous
Merger · Dissolution2 facts ▸
  • Merger
  • Dissolution, sans liquidation
07-05
State Gazette act Restructuring
Merger · Accounting effect · Capital5 facts ▸
  • Merger
  • Accounting effect, 01/01/2015
  • Capital, €2.564.780
  • Capital, €18.592
  • Shareholding, 100
2014
28-10
State Gazette act Restructuring
Merger · Accounting effect · Share issue9 facts ▸
  • Board meeting, 28/08/2014
  • Merger, absorption
  • Accounting effect, 01/07/2014
  • Share issue, 84286, 45 €
  • Share cancellation, 84286, actions propres
  • Power of attorney, Jacques Verhaegen
  • Commissaire fee, 2.500 €
  • Contribution in kind, actions BPM
  • Exchange ratio, 2 actions BEPHARBEL contre 1 action BPM
20-10
State Gazette act Resignation: ARITHMOS (director)
Appointment: VANDECASSERIE Christian (director)3 facts ▸
  • General meeting, 14/02/2014
  • Director resignation, ARITHMOS (director)
  • Director appointment, VANDECASSERIE Christian (director)
17-07
State Gazette act Resignation: SAMBRINVEST SPIN OFF SPIN OUT (director)
Appointments: Cynil WOLKONSKY, Antoine de ROCHECHOUART de MORTEMART and TALENCE · Permanent representatives: Fabrice CAROSELLA and Jean-Jacques DELENS · Capital increase12 facts ▸
  • General meeting, 26/06/2014
  • Capital increase, €114.200
  • Capital increase, €1.377.780
  • Capital, €2.564.780
  • Bank account, ING
  • Statutes amendment
  • Director resignation, SAMBRINVEST SPIN OFF SPIN OUT (director)
  • Director appointment, Cynil WOLKONSKY (director)
  • Director appointment, Antoine de ROCHECHOUART de MORTEMART (director)
  • Director appointment, TALENCE (director)
  • Permanent representative, Fabrice CAROSELLA
  • Permanent representative, Jean-Jacques DELENS
24-06
State Gazette act Appointment: VINCENT STEPHENNE (managing director)
Mandate compensation3 facts ▸
  • Board meeting, 06/12/2012
  • Director appointment, VINCENT STEPHENNE (managing director)
  • Mandate compensation, VINCENT STEPHENNE
03-01
State Gazette act Appointments: RSM INTER AUDIT (statutory auditor) and DELOITTE Réviseurs d'Entreprises (statutory auditor)
3 facts ▸
  • General meeting, 17/12/2013
  • Auditor appointment, RSM INTER AUDIT
  • Auditor appointment, DELOITTE Réviseurs d'Entreprises (statutory auditor)
2013
06-08
State Gazette act Capital & shares · Miscellaneous
Name change · Capital increase · Bank account5 facts ▸
  • Name change, BePharBel Manufacturing
  • Capital increase, €189.400
  • Bank account, BNP PARIBAS FORTIS, 284 100,00 €
  • Capital, €1.072.800
  • Statutes amendment, Article 2
06-02
State Gazette act Resignations & appointments
Name change1 fact ▸
  • Name change, BePharBel Manufacturing
2012
17-10
State Gazette act Appointments: Anne PRIGNON, SAMBRINVEST SPIN OFF SPIN OUT and 3 others
Permanent representatives: Fabrice CAROSELLA and Christian VANDECASSERIE · Capital increase · Capital9 facts ▸
  • Capital increase, €233.400
  • Capital, €883.400
  • Director appointment, Anne PRIGNON (director)
  • Director appointment, SAMBRINVEST SPIN OFF SPIN OUT (director)
  • Permanent representative, Fabrice CAROSELLA
  • Auditor appointment, RSM Inter Audit
  • Director appointment, Jean STÉPHENNE (chair)
  • Director appointment, Vincent STÉPHENNE (director (executive))
  • Permanent representative, Christian VANDECASSERIE
07-06
State Gazette act Permanent representative: C. VANDECASSERIE
Registered-office move3 facts ▸
  • Board meeting, 10/05/2012
  • Registered-office move, Rue du Luxembourg 13, 6180 Courcelles
  • Permanent representative, C. VANDECASSERIE
05-04
State Gazette act Incorporation
Appointments: Jean STÉPHENNE, Wolf Sylvain LANDAU and 2 others · Permanent representative: Christian VANDECASSERIE · Founder10 facts ▸
  • Incorporation, 21/03/2012
  • Founder, be.PharBel
  • Bank account, BNP Paribas Fortis
  • Founding capital, €650.000
  • Director appointment, Jean STÉPHENNE (director)
  • Director appointment, Wolf Sylvain LANDAU (director)
  • Director appointment, Jacques REYMANN (director)
  • Director appointment, ARITHMOS (director)
  • Permanent representative, Christian VANDECASSERIE
  • Director appointment, Jean STÉPHENNE (chair of the board)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
38 of 40 acts read
About the unread acts

Of the 40 Belgian State Gazette acts we know for this company, 38 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
17 directors, last change in 2023
Bernard Pluta
Independent director · since 10-05-2023
Current
Denis Bedoret
Independent director · since 10-05-2023
Current
Cheniclem Private Equity
Director · since 07-11-2021 · Legal entity · perm. rep.: Bernard Jolly
Current
Jacques Reymarın
Director · since 07-11-2021
Current
Jean STEPHENNE
Director · since 08-11-2017
Current
11 other directors
Stephenne Vincent
Director · since 08-11-2017
Current
Wolkonsky Cyril
Director · since 08-11-2017
Current
Yves Noël
Director · since 08-11-2017
Current
Nomainvest SA
Director · Legal entity · perm. rep.: Bernard Jolly
Current
SAMBRINVEST SO/SO
Director · Legal entity · perm. rep.: Fabrice Carosella
Current
TALENCE SA
Director · Legal entity · perm. rep.: Jean-Jacques Delens
Current
CHENICLEM PRIVATE EQUITY
Director · since 08-11-2017 · Legal entity · perm. rep.: Bernard JOLLY
Not recently confirmed
Talence
Director · since 08-11-2017 · Legal entity · perm. rep.: Jean-Jacques DELENS
Not recently confirmed
Cynil WOLKONSKY
Director · since 26-06-2014
Not recently confirmed
TALENCE
Director · since 26-06-2014 · Public limited company · perm. rep.: Jean-Jacques DELENS
Not recently confirmed
SAMBRINVEST SPIN-OFF/SPIN-OUT
Director · since 03-10-2012 · Public limited company · perm. rep.: Fabrice CAROSELLA
Not recently confirmed
08-12-2023 Anne PRIGNON: Resigned as Director
08-12-2023 Jacques Reymann: Resigned as Director
10-05-2023 Bernard Pluta: Appointed as Independent director
10-05-2023 Denis Bedoret: Appointed as Independent director
07-11-2021 Cheniclem Private Equity: Mandate renewed as Director
Full history in the Timeline (42 changes) →
Not every act has been read: a resignation may be missing here
2 of this company's 40 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Courcelles · 1 establishment unit since 2012
seat establishment The establishment unit on the map
Ground area
2.5 ha
Building footprint
3,072 m²
Volume, LiDAR
18,146 m³
Parcel 52322A0144/00A006, Wallonia · tallest building 6.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
BePharBel Manufacturing
Rue du Luxembourg(CO) 13, 6180 CourcellesManufacture of chemicals and chemical products
since 20122.208.601.611
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52322A0144/00A006 Wallonia 2.5 ha 1 · 3,072 m² 6.5 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

Deloite Reviseur d'Entreprises
Commissaire aux comptes · represented by Julie Delforge
15-05-2020 → 15-05-2020
Show 2 earlier auditors
RSM INTER AUDIT
Auditor
succeeded by SRL DELOITTE Réviseurs d'Entreprises in 2014
17-10-2012 → 03-01-2014
SRL DELOITTE Réviseurs d'Entreprises
Commissaire aux comptes
succeeded by Deloite Reviseur d'Entreprises in 2020
03-01-2014 → 15-05-2020

Articles of association

Purpose
La société a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et à l'étranger, la recherche, la fabrication, l'industrie…
Full purpose

La société a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et à l'étranger, la recherche, la fabrication, l'industrie, l'achat, la vente, le conditionnement, l'importation et l'exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, diététiques, phytopharmaceutiques, homéopathiques, vétérinaires et d'herboristerie; -de tous articles de droguerie en général, de parfumerie, de cosmétiques, d'hygiène et d'entretien; -d'accessoires médicaux et chirurgicaux, d'acoustique, d'optique, d'orthopédie et de bandages; de tous autres produits se rapportant d'une façon quelconque aux articles repris ci-dessus et pouvant y être adjoints utilement; -Le développement, l'exploitation et la commercialisation d'équipements et d'accessoires relatifs aux activités de recherche, développement, production et commercialisation des produits et articles repris ci-dessus -La vente de tous livres ou supports papier ou électronique en rapport avec son objet; et en général toutes activités intéressant l'approvisionnement de l'industrie chimique, des hôpitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des matières et produits similaires et connexes. La société peut de manière générale, entreprendre toutes opérations de commerce, d'industrie et de finance, mobilières et immobilières, dans toutes entreprises dont l'objet se rattache directement ou indirectement à son industrie ou son commerce/ en tout ou en partie à son objet ou qui seraient de nature à en faciliter ou à développer la réalisation/ La société peut également exercer toute activité d'ingénieur conseil, de bureau d'études, de conception ou réalisation d'appareils ou d'entreprises publique ou privée- y compris l'organisation- rien excepté ni réservé. La société peut s'intéresser par voie d'apport, de fusion, de souscription, d'association, de cession, ou achat de titres ou droits sociaux, ou de toute autre manière dans toutes sociétés, entreprises ou associations existantes ou à créer en Belgique ou à l'étranger, dont l'objet se rattache directement ou indirectement à son industrie ou son commerce/ à son objet ou simplement susceptible d'accroitre son activité sociale. La société pourra acquérir, exploiter et céder des brevets ou licences ayant trait, directement ou indirectement, aux opérations se rapportant à l'objet. Cette énumération est simplement énonciative et nullement limitative.

Structure & network

Connections & network

59 connected companies
Linked via shared directors
Innosté
via Jean STEPHENNE · Permanent representative
→
NOMAINVEST
via Yves Noël · Director
→
former→
BESIX Group
via Jean STEPHENNE · Permanent representative
former→
Show 55 more companies with a shared director
BioPharma Management and Consulting
via Denis Bedoret · Permanent representative
former→
BioSenic
via Jean STEPHENNE · Director
former→
former→
Catalent Gosselies
via Denis Bedoret · Toutes ses fonctions au sein du conseil d'administration
former→
CERAN
via Yves Noël · Director
former→
former→
Fondation Saint - Luc
via Jean STEPHENNE · Class B director
former→
former→
former→
INVESTSUD
via Yves Noël · Director
former→
MEDIAFIN
via Jean STEPHENNE · Director
former→
n-Side
via Jean STEPHENNE · Director
former→
NANOCYL
via Jean STEPHENNE · Director
former→
OncoDNA
via Jean STEPHENNE · Director
former→
SOPARTEC
via Jean STEPHENNE · Director
former→
SPARKOH!
via Jean STEPHENNE · Director
former→
6K venture capital
Shared director
→
AEDIFICAS
Shared director
→
AZIMUT Entreprendre
Shared director
→
→
→
→
EPSYMMO
Shared director
→
→
→
IMBC 2020
Shared director
→
IMBC CAPITAL RISQUE
Shared director
→
ImmunXperts
Shared director
→
SAMBRELEASE
Shared director
→
Starter Fund
Shared director
→
→
SUD - CONSTRUCT
Shared director
→
VAHF
Shared director
→
Catalent Gosselies PS
Shared corporate director
→
DIGITAL ATTRAXION
Shared corporate director
→
DREAMWALL
Shared corporate director
→
IP Trade
Shared corporate director
→
SPRIMO VITRO
Shared corporate director
→
THEODORUS IV
Shared corporate director
→

Acquisitions and mergers

3 transactions
Took over:BePharBel
BE 0843.905.938merger by absorption · State Gazette act of 21-05-2025 (3 acts) · effective 18-04-2025
Took over:ECONOPHAR
BE 0432.322.862State Gazette act of 16-07-2015 (2 acts)
Split off to:Novaform Pharma
BE 1040.218.595partial demerger · State Gazette act of 11-08-2026 (2 acts) · effective 10-07-2026

Capital and shareholders

Shareholders according to the acts
At incorporation act of 05-04-2012 ↗
  • be.PharBel (BE 0843.905.938) sole founder · 100% at incorporation

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 11-08-2026 Capital reduction of 4,238,390 EUR · to 7,664,142.35 EUR
  2. 08-09-2025 Capital increase of 2,173,956.35 EUR · to 10,412,687.63 EUR · 165,192 new shares
  3. 08-09-2025 Capital increase of 2,160,256.61 EUR · to 12,572,944.23 EUR · 164,151 new shares
  4. 08-09-2025 Capital increase of 536,343.11 EUR · to 13,109,287.35 EUR · 40,755 new shares
  5. 04-06-2025 Capital increase of 357,562.07 EUR · to 8,238,731.27 EUR · 27,170 new shares
  6. 04-06-2025 Capital increase of 2,195,605.31 EUR · to 10,434,336.58 EUR · 166,874 new shares
  7. 04-06-2025 Capital increase of 2,232,780.34 EUR · to 12,667,116.92 EUR · 169,700 new shares
  8. 04-06-2025 Capital increase of 536,343.11 EUR · to 13,203,460.03 EUR · 40,755 new shares
Show 23 older capital entries
  1. 21-05-2025 Capital increase of 1,182,819 EUR · to 7,881,169.20 EUR · 87,928 new shares
  2. 27-02-2025 Capital reduction of 1,206,755 EUR · “destruction des actions propres”
  3. 06-10-2023 Capital increase of 21,470.52 EUR · to 6,392,344.30 EUR
  4. 06-10-2023 Capital increase of 306,010.83 EUR · to 6,698,355.13 EUR
  5. 04-05-2022 Capital increase of 239,184.92 EUR · to 6,370,873.78 EUR · 21,394 new shares
  6. 26-10-2021 Capital increase of 236,479.36 EUR · to 6,131,688.86 EUR · 21,152 new shares
  7. 07-07-2021 Capital stated in the act · 5,895,209.50 EUR · 527,169 shares
  8. 23-10-2020 Capital increase of 6,979,040.06 EUR · to 11,050,000 EUR · no new shares · from reserves
  9. 23-10-2020 Capital increase of 1,079,114 EUR · to 12,129,114 EUR · 46,918 new shares · in cash
  10. 12-07-2019 Capital increase of 178,554.88 EUR · to 4,070,959.94 EUR · 21,056 new shares
  11. 10-04-2019 Capital increase of 178,554.88 EUR · to 3,892,405.06 EUR · 21,056 new shares
  12. 12-10-2018 Capital increase of 356,925.09 EUR · to 3,713,850.18 EUR · 42,108 new shares
  13. 19-03-2018 Capital increase of 356,925.09 EUR · to 3,356,925.09 EUR · 42,108 new shares
  14. 11-01-2018 Capital reduction of 539,230 EUR · to 3,000,000 EUR · to absorb losses
  15. 28-11-2017 Capital increase of 421,060 EUR · to 3,539,230 EUR · 42,106 new shares
  16. 12-04-2017 Capital increase of 289,670 EUR · to 3,118,170 EUR · 28,967 new shares
  17. 11-07-2016 Capital increase of 263,720 EUR · to 2,828,500 EUR · 26,372 new shares
  18. 07-05-2015 Capital stated in the act · 2,564,780 EUR · 256,478 shares
  19. 17-07-2014 Capital increase of 114,200 EUR · to 1,187,000 EUR · in kind
  20. 17-07-2014 Capital increase of 1,377,780 EUR · to 2,564,780 EUR · in cash
  21. 06-08-2013 Capital increase of 189,400 EUR · to 1,072,800 EUR · 18,940 new shares
  22. 17-10-2012 Capital increase of 233,400 EUR · to 883,400 EUR
  23. 05-04-2012 Incorporation · 650,000 EUR · 65,000 shares

Recognitions · licences · registrations

Food safety, FASFC

1 site
Courcelles2.208.601.611
1 permission
Toelating · Fabrikant voedingssupplementen · since 16-04-2014

Legal Entity Identifier

967600GGQV7ZJA8NN995
live in the LEI register

Similar companies · same sector, comparable size

Of 148 companies in sector 21201 we hold annual accounts for 116. 63 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded26-03-2012
Fiscal year end31-12
Activities, NACEBEL 2025
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods

Scores and ratios are computed by Checked and are not a credit decision.